Cancer Incidence and Mortality for Allegany County, 2016-2020

Source: New York State Cancer Registry

Site of Cancer Incidence Mortality
Males and Females Males Females Males and Females Males Females
Average Annual Cases Rate per 100,000 Population 95% CI Average Annual Cases Rate per 100,000 Males 95% CI Average Annual Cases Rate per 100,000 Females 95% CI Average Annual Deaths Rate per 100,000 Population 95% CI Average Annual Deaths Rate per 100,000 Males 95% CI Average Annual Deaths Rate per 100,000 Females 95% CI
All Invasive Malignant Tumors 299.0 484.1 458.6-510.8 160.2 515.5 478.9-554.2 138.8 458.1 422.2-496.4 105.4 162.4 148.4-177.5 55.2 180.4 159.1-204.0 50.2 147.0 128.7-167.6
Oral cavity and pharynx 8.0 13.0 9.0-18.2 6.6 21.7 14.5-31.5 1.4 4.3 1.6-9.8 1.6 2.7 1.1-5.6 1.6 5.5 2.3-11.5 0.0 0.0 0.0-3.5
Esophagus 3.0 4.3 2.4-7.5 2.2 6.6 3.2-12.5 0.8 2.3 0.6-6.8 2.8 4.2 2.3-7.4 2.4 8.1 4.1-14.7 0.4 0.9 0.1-4.7
Stomach 5.4 8.8 5.7-13.2 3.2 10.2 5.7-17.1 2.2 7.7 3.7-14.5 1.0 1.5 0.5-3.9 0.6 2.2 0.5-7.0 0.4 0.9 0.1-4.7
Colorectal 26.0 43.6 36.1-52.4 15.0 52.9 41.1-67.1 11.0 35.2 25.9-47.0 10.4 16.6 12.3-22.2 4.2 14.3 8.7-22.5 6.2 18.2 12.1-26.8
Colon excluding rectum 18.6 31.6 25.1-39.3 10.2 36.7 26.9-49.0 8.4 27.5 19.2-38.3 9.0 14.7 10.6-20.1 3.6 12.8 7.4-20.7 5.4 16.2 10.3-24.5
Rectum & rectosigmoid 7.4 12.1 8.4-17.0 4.8 16.2 10.1-24.8 2.6 7.7 4.1-13.9 1.4 1.9 0.8-4.4 0.6 1.5 0.3-5.5 0.8 2.0 0.5-6.3
Liver / intrahepatic bile duct 3.6 5.2 3.1-8.6 2.4 7.1 3.6-13.0 1.2 3.6 1.3-8.6 2.6 4.0 2.1-7.1 1.6 5.1 2.2-10.7 1.0 3.2 1.0-8.2
Pancreas 9.0 12.9 9.4-17.6 4.6 13.1 8.2-20.3 4.4 12.6 7.8-19.7 6.2 9.4 6.3-13.7 2.8 8.1 4.4-14.3 3.4 10.4 5.9-17.4
Larynx 2.8 4.0 2.2-7.0 2.6 7.3 3.9-13.2 0.2 0.6 0.0-4.3 1.0 1.4 0.4-3.7 0.8 2.4 0.6-6.8 0.2 0.5 0.0-4.1
Lung and bronchus 45.6 67.6 59.0-77.4 23.6 72.0 59.3-86.9 22.0 63.9 52.3-77.8 28.2 41.3 34.6-49.0 16.0 49.7 39.2-62.5 12.2 33.7 25.7-43.9
Melanoma of the skin 16.6 30.0 23.5-37.7 10.2 35.4 26.1-47.2 6.4 26.1 17.2-37.9 1.8 2.8 1.2-5.6 1.4 4.5 1.8-10.0 0.4 1.5 0.2-5.9
Female breast             37.0 130.1 110.5-152.3             7.2 21.6 14.9-30.6
Cervix uteri             1.6 6.5 2.6-13.4             1.2 4.7 1.5-11.0
Corpus uterus and NOS             11.6 36.6 27.2-48.4             2.0 6.1 2.8-12.1
Ovary             3.2 9.6 5.3-16.4             3.6 10.4 6.0-17.2
Prostate       38.8 115.3 99.2-133.6             5.2 17.6 11.4-26.3      
Testis       1.2 4.6 1.5-10.5             0.0 0.0 0.0-3.4      
Urinary bladder (incl. in situ) 15.8 25.4 19.9-32.1 12.8 42.5 32.4-55.0 3.0 9.6 5.1-16.7 3.0 4.8 2.6-8.2 2.2 8.1 3.9-15.0 0.8 2.2 0.6-6.5
Kidney and renal pelvis 10.4 16.9 12.4-22.7 6.4 20.4 13.7-29.5 4.0 13.6 7.9-22.1 2.6 4.3 2.2-7.7 2.2 7.8 3.7-14.5 0.4 1.1 0.1-5.1
Brain and other central nervous system 3.0 5.0 2.7-8.6 1.8 6.6 2.8-13.2 1.2 3.2 1.2-7.8 2.2 3.3 1.6-6.3 1.4 3.8 1.5-8.7 0.8 2.8 0.7-7.9
Thyroid 4.4 9.9 6.1-15.2 1.4 7.3 2.9-15.0 3.0 12.6 6.8-21.2 0.0 0.0 0.0-1.7 0.0 0.0 0.0-3.4 0.0 0.0 0.0-3.5
Hodgkin lymphoma 2.0 4.1 1.8-7.7 0.8 3.3 0.8-8.8 1.2 4.9 1.6-11.2 0.2 0.3 0.0-2.3 0.2 0.7 0.0-4.6 0.0 0.0 0.0-3.5
Non-Hodgkin lymphomas 10.6 17.2 12.6-23.0 5.8 19.8 12.9-29.3 4.8 15.1 9.4-23.4 3.0 4.9 2.6-8.4 1.6 6.0 2.4-12.5 1.4 3.9 1.5-8.8
Myeloma 2.0 2.8 1.3-5.5 1.6 4.5 1.9-9.7 0.4 0.9 0.1-4.7 1.0 1.6 0.5-4.0 0.6 2.0 0.4-6.5 0.4 0.9 0.1-4.7
Leukemias 7.6 12.6 8.8-17.6 4.8 16.9 10.6-25.6 2.8 8.6 4.5-15.1 3.6 6.2 3.6-10.0 2.0 7.5 3.6-14.2 1.6 4.6 2.0-9.9

Notes

  • Incidence data are provisional, November 2022.
  • Rates are per 100,000 persons, age-adjusted to the 2000 US standard population, with 95% confidence intervals.
  • Rates based on fewer than 4 cases or deaths per year are unstable and should be used with caution. NOS = Not otherwise specified.